KRAS and KIT gatekeeper mutations confer polyclonal primary imatinib resistance in GI stromal tumors: Relevance of concomitant phosphatidylinositol 3-kinase/AKT dysregulation

César Serrano, Yuexiang Wang, Adrián Mariño-Enríquez, Jen Chieh Lee, Gloria Ravegnini, Jeffrey A. Morgan, Monica M. Bertagnolli, Carol Beadling, George D. Demetri, Christopher L. Corless, Michael C. Heinrich, Jonathan A. Fletcher

Research output: Contribution to journalArticle

25 Scopus citations

Fingerprint Dive into the research topics of 'KRAS and KIT gatekeeper mutations confer polyclonal primary imatinib resistance in GI stromal tumors: Relevance of concomitant phosphatidylinositol 3-kinase/AKT dysregulation'. Together they form a unique fingerprint.